Content for site developed under the guidance of the TRACK Advisory Council.

Victor F. Tapson, MD

Dr Victor Tapson is a professor of medicine at the Division of Pulmonary and Critical Care Medicine at Duke University Medical Center and also serves as director of the Duke Pulmonary Vascular Disease Center. He spent 10 years as medical director of the Duke University Lung Transplant Program. He became a fellow in Pulmonary Medicine in 1986 at Boston University Medical Center and Boston City Hospital in Boston, Massachusetts, USA.

Dr Tapson has received several awards for his work including the American College of Chest Physicians (ACCP) Ciba-Geigy Fellowship Award, Alfred Soffer Research Award, and Young Investigators Award. He is chairman of the Consensus Statements for the Diagnostic Approach to Acute Venous Thromboembolism and the Therapeutic Approach to Acute Venous Thromboembolism of the American Thoracic Society, and has served as a contributor to ACCP Consensus Statements on Antithrombotic Therapy. He is also an active member of several societies, including the Pulmonary Hypertension Association Scientific Leadership Committee, the Pulmonary Circulation Assembly of the American Thoracic Society, and the International Society on Thrombosis and Haemostasis.

Dr Tapson has authored over 140 papers in peer-reviewed journals and more than 10 book chapters. He was an editor for 2 issues of Clinics in Chest Medicine on venous thromboembolism (VTE) and has chaired more than 50 symposia on the topic at national and international meetings. He has lectured at the Royal College of Physicians in Edinburgh and at both the American College of Chest Physicians and the American Thoracic Society every year for the past decade. Dr Tapson’s primary research interest is pulmonary vascular disease including VTE and pulmonary hypertension. He has been appointed the principal investigator of a number of clinical trials, including Extended Clinical Prophylaxis in Acutely Ill Medical Patients (EXCLAIM), DVT-FREE, and the International Medical Prophylaxis Registry on Venous Thromboembolism (IMPROVE).